Home

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

CIK 1280238 · last filed 2013-04-16

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing, for CMRX, was dated Apr 16, 2013. Across all open-market trades the lifetime net is −$5.4M, making them a net seller over the disclosed history. The firm reports its address in San Francisco, CA. 29 SEC filings were submitted jointly with ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

3

Lifetime Open-Market Net

-$5.43M

Filer Profile

Reported Address
ONE EMBARCADERO CENTER, SUITE 4050
SAN FRANCISCO, CA 94111
Phone
(415) 362-4022
Related Filers
ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG — 29 joint filings, latest 2014-02-05
ALTA BIOPHARMA PARTNERS III LP — 24 joint filings, latest 2014-02-05
FARAH CHAMPSI — 16 joint filings, latest 2014-02-05
EDWARD PENHOET — 16 joint filings, latest 2014-02-05
EDWARD HURWITZ — 12 joint filings, latest 2014-02-05
JEAN DELEAGE — 9 joint filings, latest 2010-10-27
DANIEL JANNEY — 8 joint filings, latest 2007-01-09
Alison Kiley — 1 joint filings, latest 2012-10-17
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CHIMERIX INC (CMRX) Delisted 1,515,203 $8.54 $12.94M $0 1 2013-04-16
Aegerion Pharmaceuticals, Inc. (AEGR) Delisted 10%+ Owner 2,339,547 — — -$5.43M 2 2012-10-17

Recent Filings

3 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2013-04-16 CHIMERIX INC (CMRX) Delisted Conv (C) +6,198,555 $0 EDGAR
2012-10-17 Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Sell (S) −1,605,864 -$29.43M EDGAR
2010-10-27 Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Mixed +21,444,408 $70.47M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.